New Key Statistics Module, Z-Score and F-Score
AMEX:CATX Key Ratios
| Market Cap $ M | 908.25 |
| Enterprise Value $ M | 611.16 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 2.66 |
| Price/Sales | -- |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -3.00 |
| EPS (TTM) $ | -1.68 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | 3.80 |
| 5-y EBITDA Growth Rate % | 2.10 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -14.59 |
| EV-to-EBITDA | -15.10 |
| PEG | -- |
| Shares Outstanding M | 67.43 |
| Net Margin (%) | 1,772.34 |
| Operating Margin % | 1,394.93 |
| Pre-tax Margin (%) | 1,260.93 |
| Quick Ratio | 27.73 |
| Current Ratio | 27.73 |
| ROA % (ttm) | -29.72 |
| ROE % (ttm) | -34.58 |
| ROIC % (ttm) | -60.43 |
| Dividend Yield % | -- |
| Altman Z-Score | 11.90 |
CATX Number of Guru Trades
CATX Volume of Guru Trades
Gurus Latest Trades with AMEX:CATX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
AMEX:CATX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Perspective Therapeutics Inc Insider Transactions
No Available Data
News about AMEX:CATX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers